178 related articles for article (PubMed ID: 34075107)
41. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.
Wang Q; Tiffen J; Bailey CG; Lehman ML; Ritchie W; Fazli L; Metierre C; Feng YJ; Li E; Gleave M; Buchanan G; Nelson CC; Rasko JE; Holst J
J Natl Cancer Inst; 2013 Oct; 105(19):1463-73. PubMed ID: 24052624
[TBL] [Abstract][Full Text] [Related]
42. Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids.
Pineda M; Fernández E; Torrents D; Estévez R; López C; Camps M; Lloberas J; Zorzano A; Palacín M
J Biol Chem; 1999 Jul; 274(28):19738-44. PubMed ID: 10391915
[TBL] [Abstract][Full Text] [Related]
43. Characterization of substrates and inhibitors of the human heterodimeric transporter 4F2hc-LAT1 using purified protein and the scintillation proximity radioligand binding assay.
Kantipudi S; Harder D; Fotiadis D
Front Physiol; 2023; 14():1148055. PubMed ID: 36895635
[TBL] [Abstract][Full Text] [Related]
44. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.
Kageyama T; Nakamura M; Matsuo A; Yamasaki Y; Takakura Y; Hashida M; Kanai Y; Naito M; Tsuruo T; Minato N; Shimohama S
Brain Res; 2000 Oct; 879(1-2):115-21. PubMed ID: 11011012
[TBL] [Abstract][Full Text] [Related]
45. Up-regulation of L-type amino acid transporter 1 (LAT1) in cultured rat retinal capillary endothelial cells in response to glucose deprivation.
Matsuyama R; Tomi M; Akanuma S; Tabuchi A; Kubo Y; Tachikawa M; Hosoya K
Drug Metab Pharmacokinet; 2012; 27(3):317-24. PubMed ID: 22185814
[TBL] [Abstract][Full Text] [Related]
46. Don't trust an(t)ybody - Pitfalls during investigation of candidate proteins for methylmercury transport at the placental interface.
Ellinger I; Chatuphonprasert W; Reiter M; Voss A; Kemper J; Straka E; Scheinast M; Zeisler H; Salzer H; Gundacker C
Placenta; 2016 Jul; 43():13-6. PubMed ID: 27324094
[TBL] [Abstract][Full Text] [Related]
47. Stimulation of system y(+)-like amino acid transport by the heavy chain of human 4F2 surface antigen in Xenopus laevis oocytes.
Bertran J; Magagnin S; Werner A; Markovich D; Biber J; Testar X; Zorzano A; Kühn LC; Palacin M; Murer H
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5606-10. PubMed ID: 1376926
[TBL] [Abstract][Full Text] [Related]
48. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
Yanagida O; Kanai Y; Chairoungdua A; Kim DK; Segawa H; Nii T; Cha SH; Matsuo H; Fukushima J; Fukasawa Y; Tani Y; Taketani Y; Uchino H; Kim JY; Inatomi J; Okayasu I; Miyamoto K; Takeda E; Goya T; Endou H
Biochim Biophys Acta; 2001 Oct; 1514(2):291-302. PubMed ID: 11557028
[TBL] [Abstract][Full Text] [Related]
49. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity.
Hahm ER; Singh SV
Mol Cancer Ther; 2007 Oct; 6(10):2686-95. PubMed ID: 17938262
[TBL] [Abstract][Full Text] [Related]
50. Targeting L-type amino acid transporter 1 in urological malignancy: Current status and future perspective.
Pae S; Sakamoto S; Zhao X; Saito S; Tamura T; Imamura Y; Sazuka T; Reien Y; Hirayama Y; Hashimoto H; Kanai Y; Ichikawa T; Anzai N
J Pharmacol Sci; 2022 Dec; 150(4):251-258. PubMed ID: 36344047
[TBL] [Abstract][Full Text] [Related]
51. Molecular events involved in up-regulating human Na+-independent neutral amino acid transporter LAT1 during T-cell activation.
Nii T; Segawa H; Taketani Y; Tani Y; Ohkido M; Kishida S; Ito M; Endou H; Kanai Y; Takeda E; Miyamoto Ki
Biochem J; 2001 Sep; 358(Pt 3):693-704. PubMed ID: 11535130
[TBL] [Abstract][Full Text] [Related]
52. Regulation of 4F2 heavy-chain gene expression during normal human T-cell activation can be mediated by multiple distinct molecular mechanisms.
Lindsten T; June CH; Thompson CB; Leiden JM
Mol Cell Biol; 1988 Sep; 8(9):3820-6. PubMed ID: 3265471
[TBL] [Abstract][Full Text] [Related]
53. Function and structure of heterodimeric amino acid transporters.
Wagner CA; Lang F; Bröer S
Am J Physiol Cell Physiol; 2001 Oct; 281(4):C1077-93. PubMed ID: 11546643
[TBL] [Abstract][Full Text] [Related]
54. Inhibiting the role of Skp2 suppresses cell proliferation and tumorigenesis of human gastric cancer cells via the upregulation of p27kip1.
Wen Y; Wang K; Yang K
Mol Med Rep; 2016 Oct; 14(4):3917-24. PubMed ID: 27572672
[TBL] [Abstract][Full Text] [Related]
55. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
[TBL] [Abstract][Full Text] [Related]
56. Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells.
Rico-Bautista E; Yang CC; Lu L; Roth GP; Wolf DA
BMC Biol; 2010 Dec; 8():153. PubMed ID: 21182779
[TBL] [Abstract][Full Text] [Related]
57. Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.
Yang G; Ayala G; De Marzo A; Tian W; Frolov A; Wheeler TM; Thompson TC; Harper JW
Clin Cancer Res; 2002 Nov; 8(11):3419-26. PubMed ID: 12429629
[TBL] [Abstract][Full Text] [Related]
58. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.
Nawashiro H; Otani N; Shinomiya N; Fukui S; Ooigawa H; Shima K; Matsuo H; Kanai Y; Endou H
Int J Cancer; 2006 Aug; 119(3):484-92. PubMed ID: 16496379
[TBL] [Abstract][Full Text] [Related]
59. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.
Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT
Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890
[TBL] [Abstract][Full Text] [Related]
60. WIF1, a Wnt pathway inhibitor, regulates SKP2 and c-myc expression leading to G1 arrest and growth inhibition of human invasive urinary bladder cancer cells.
Tang Y; Simoneau AR; Liao WX; Yi G; Hope C; Liu F; Li S; Xie J; Holcombe RF; Jurnak FA; Mercola D; Hoang BH; Zi X
Mol Cancer Ther; 2009 Feb; 8(2):458-68. PubMed ID: 19174556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
